已收盘 02-06 16:00:00 美东时间
+1.530
+3.61%
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
今日重点评级关注:Canaccord Genuity:维持Wave Life Sciences Ltd."买入"评级,目标价从40美元升至43美元;花旗:维持Palantir Technologies"买入"评级,目标价从235美元升至260美元
02-04 12:15
HC Wainwright & Co. analyst Robert Burns reiterates Exelixis (NASDAQ:EXEL) with a Buy and maintains $52 price target.
02-03 21:03
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-27 20:55
Tempus AI, Inc. Class A涨7.89%;哈莫尼黄金涨7.64%;Sibanye Stillwater Limited Sponsored ADR涨7.41%
01-12 17:20
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
Morgan Stanley analyst Sean Laaman downgrades Exelixis (NASDAQ:EXEL) from Overweight to Equal-Weight and raises the price target from $45 to $48.
01-08 20:18
Exelixis shares are trading higher after the company announced a collaboration ...
01-08 02:31
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价;Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
2025-11-07 10:14
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
2025-11-06 09:55